Need help finding what you are looking for?
Contact Us
PUBLISHER: KBV Research | PRODUCT CODE: 1335501
PUBLISHER: KBV Research | PRODUCT CODE: 1335501
Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market Size, Share & Industry Trends Analysis Report By Product, By End User, By Testing Type, By Technology, By Country and Growth Forecast, 2023 - 2030
PUBLISHED:
PAGES: 136 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market would witness market growth of 7.9% CAGR during the forecast period (2023-2030).
The rise in the prevalence of sexually transmitted diseases is the main factor fueling the market. Molecular chlamydia trachomatis (CT)/Neisseria gonorrhoeae (NG) diagnostic equipment is expected to expand rapidly over the study period due to increasing emphasis on awareness-raising efforts and government initiatives. Furthermore, businesses competing in the market may benefit greatly from the soaring need for cutting-edge CT/NG testing equipment in the upcoming years.
The healthcare industry will change due to technological developments like point-of-care testing tools and rapid diagnostic techniques, making testing options more accessible and quicker. Furthermore, incorporating molecular diagnostics and genotyping methods will improve the precision and specificity of CT/NG testing, enabling individualized treatment strategies. Additionally, the expanding use of telemedicine and digital health platforms will make remote testing and result distribution possible, guaranteeing comfort and privacy for any individual seeking CT/NG testing services.
The number of sexual health screens (SHSs) that performed diagnostic tests for chlamydia, gonorrhoea, syphilis, or HIV in 2022 was 2,195,909, up 13.4% from 2021 (1,936,455), according to the U.K. government. All ages of people are experiencing an increase in gonorrhoea, although young adults between the ages of 15 to 24 are most affected. Gonorrhoea diagnoses grew to 82,592 diagnoses in 2022, an increase of 50.3% compared to 2021 (54,961), while chlamydia diagnoses (all ages) increased by 24.3% from 160,279 diagnoses in 2021 to 199,233 in 2022. Through the National Chlamydia Screening Programme (NCSP), young women between the ages of 15 to 24 were screened. In 2022, 690,531 chlamydia tests were performed, a 1.2% decrease from 2021 (698,979), and 68,882 chlamydia diagnoses were made, a 21.8% increase from 2021 (56,562). Over the same time, test positivity rose from 8.1% to 10.0%. The market is anticipated to expand in this region due to the rising number of chlamydia diseases.
The Germany market dominated the Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $180 million by 2030. The UK market is exhibiting a CAGR of 7% during (2023 - 2030). Additionally, The France market would experience a CAGR of 8.7% during (2023 - 2030).
Based on Product, the market is segmented into Assays & Kits, and Instruments & Analyzers. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics, and Others. Based on Testing Type, the market is segmented into Lab Tests, and PoC Tests. Based on Technology, the market is segmented into Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction, Immunodiagnostics, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, ZeptoMetrix LLC (Antylia Scientific), Danaher Corporation, F. Hoffmann-La Roche Ltd., Hologic, Inc., Thermo Fisher Scientific, Inc., Bayer AG, Qiagen N.V. and Siemens AG.
Scope of the Study
Market Segments covered in the Report:
By Product
- Assays & Kits
- Instruments & Analyzers
By End User
- Diagnostic Laboratories
- Hospitals & Clinics
- Others
By Testing Type
- Lab Tests
- PoC Tests
By Technology
- Isothermal Nucleic Acid Amplification Technology
- Polymerase Chain Reaction
- Immunodiagnostics
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- Abbott Laboratories
- Becton, Dickinson and Company
- ZeptoMetrix LLC (Antylia Scientific)
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
- Hologic, Inc.
- Thermo Fisher Scientific, Inc.
- Bayer AG
- Qiagen N.V.
- Siemens AG
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by Product
- 1.4.2 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by End User
- 1.4.3 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by Testing Type
- 1.4.4 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by Technology
- 1.4.5 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter's Five Forces Analysis
Chapter 4. Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 4.1 Europe Assays & Kits Market by Country
- 4.2 Europe Instruments & Analyzers Market by Country
Chapter 5. Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 5.1 Europe Diagnostic Laboratories Market by Country
- 5.2 Europe Hospitals & Clinics Market by Country
- 5.3 Europe Others Market by Country
Chapter 6. Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 6.1 Europe Lab Tests Market by Country
- 6.2 Europe PoC Tests Market by Country
Chapter 7. Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 7.1 Europe Isothermal Nucleic Acid Amplification Technology Market by Country
- 7.2 Europe Polymerase Chain Reaction Market by Country
- 7.3 Europe Immunodiagnostics Market by Country
- 7.4 Europe Others Market by Country
Chapter 8. Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country
- 8.1 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.1.1 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.1.2 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.1.3 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.1.4 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 8.2 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.2.1 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.2.2 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.2.3 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.2.4 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 8.3 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.3.1 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.3.2 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.3.3 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.3.4 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 8.4 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.4.1 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.4.2 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.4.3 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.4.4 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 8.5 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.5.1 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.5.2 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.5.3 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.5.4 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 8.6 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.6.1 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.6.2 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.6.3 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.6.4 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 8.7 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.7.1 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.7.2 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.7.3 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.7.4 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
Chapter 9. Company Profiles
- 9.1 Abbott Laboratories
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 Recent strategies and developments:
- 9.1.5.1 Trials & Approvals:
- 9.1.6 SWOT Analysis
- 9.2 Becton, Dickinson, and Company
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Product Launches and Product Expansions:
- 9.2.6 SWOT Analysis
- 9.3 ZeptoMetrix LLC (Antylia Scientific)
- 9.3.1 Company Overview
- 9.3.2 SWOT Analysis
- 9.4 Danaher Corporation
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 SWOT Analysis
- 9.5 F. Hoffmann-La Roche Ltd.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 Recent strategies and developments:
- 9.5.5.1 Trials & Approvals:
- 9.5.6 SWOT Analysis
- 9.6 Hologic, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 SWOT Analysis
- 9.7 Thermo Fisher Scientific, Inc.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 SWOT Analysis
- 9.8 Bayer AG
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expense
- 9.8.5 SWOT Analysis
- 9.9 Qiagen N.V.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 SWOT Analysis
- 9.10. Siemens AG
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expense
- 9.10.5 SWOT Analysis
LIST OF TABLES
- TABLE 1 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 2 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 3 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 4 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 5 Europe Assays & Kits Market by Country, 2019 - 2022, USD Million
- TABLE 6 Europe Assays & Kits Market by Country, 2023 - 2030, USD Million
- TABLE 7 Europe Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
- TABLE 8 Europe Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
- TABLE 9 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 10 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 11 Europe Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
- TABLE 12 Europe Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
- TABLE 13 Europe Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
- TABLE 14 Europe Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
- TABLE 15 Europe Others Market by Country, 2019 - 2022, USD Million
- TABLE 16 Europe Others Market by Country, 2023 - 2030, USD Million
- TABLE 17 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 18 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 19 Europe Lab Tests Market by Country, 2019 - 2022, USD Million
- TABLE 20 Europe Lab Tests Market by Country, 2023 - 2030, USD Million
- TABLE 21 Europe PoC Tests Market by Country, 2019 - 2022, USD Million
- TABLE 22 Europe PoC Tests Market by Country, 2023 - 2030, USD Million
- TABLE 23 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 24 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 25 Europe Isothermal Nucleic Acid Amplification Technology Market by Country, 2019 - 2022, USD Million
- TABLE 26 Europe Isothermal Nucleic Acid Amplification Technology Market by Country, 2023 - 2030, USD Million
- TABLE 27 Europe Polymerase Chain Reaction Market by Country, 2019 - 2022, USD Million
- TABLE 28 Europe Polymerase Chain Reaction Market by Country, 2023 - 2030, USD Million
- TABLE 29 Europe Immunodiagnostics Market by Country, 2019 - 2022, USD Million
- TABLE 30 Europe Immunodiagnostics Market by Country, 2023 - 2030, USD Million
- TABLE 31 Europe Others Market by Country, 2019 - 2022, USD Million
- TABLE 32 Europe Others Market by Country, 2023 - 2030, USD Million
- TABLE 33 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2019 - 2022, USD Million
- TABLE 34 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2023 - 2030, USD Million
- TABLE 35 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 36 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 37 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 38 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 39 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 40 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 41 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 42 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 43 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 44 Germany Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 45 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 46 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 47 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 48 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 49 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 50 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 51 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 52 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 53 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 54 UK Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 55 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 56 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 57 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 58 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 59 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 60 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 61 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 62 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 63 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 64 France Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 65 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 66 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 67 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 68 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 69 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 70 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 71 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 72 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 73 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 74 Russia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 75 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 76 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 77 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 78 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 79 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 80 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 81 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 82 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 83 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 84 Spain Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 85 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 86 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 87 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 88 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 89 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 90 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 91 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 92 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 93 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 94 Italy Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 95 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 96 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 97 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 98 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 99 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 100 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 101 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 102 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 103 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 104 Rest of Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 105 Key Information - Abbott Laboratories
- TABLE 106 Key information - Becton, Dickinson and Company
- TABLE 107 Key Information - ZeptoMetrix LLC
- TABLE 108 Key Information - Danaher Corporation
- TABLE 109 Key Information - F. Hoffmann-La Roche Ltd.
- TABLE 110 Key Information - Hologic, Inc.
- TABLE 111 Key Information - Thermo Fisher Scientific, Inc.
- TABLE 112 Key Information - Bayer AG
- TABLE 113 Key Information - Qiagen N.V.
- TABLE 114 Key Information - Siemens AG
List of Figures
- FIG 1 Methodology for the research
- FIG 2 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2030, USD Million
- FIG 3 Key Impacting Factors chlamydia trachomatis/neisseria gonorrhoeae (CT/NG) testing market
- FIG 4 Porter's Five Forces Analysis - Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- FIG 5 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Product, 2022
- FIG 6 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Product, 2030
- FIG 7 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2030, USD Million
- FIG 8 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by End User, 2022
- FIG 9 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by End User, 2030
- FIG 10 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2030, USD Million
- FIG 11 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Testing Type, 2022
- FIG 12 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Testing Type, 2030
- FIG 13 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2030, USD Million
- FIG 14 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Technology, 2022
- FIG 15 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Technology, 2030
- FIG 16 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2030, USD Million
- FIG 17 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Country, 2022
- FIG 18 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Country, 2030
- FIG 19 Europe Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2019 - 2030, USD Million
- FIG 20 SWOT Analysis: Abbott Laboratories
- FIG 21 SWOT Analysis: Becton, Dickinson and company
- FIG 22 SWOT Analysis: Becton, Dickinson and company
- FIG 23 SWOT Analysis: Danaher Corporation
- FIG 24 Swot Analysis: F. Hoffmann-La Roche Ltd.
- FIG 25 Swot Analysis: Hologic, Inc.
- FIG 26 Swot Analysis: Thermo Fisher Scientific, Inc.
- FIG 27 Swot Analysis: Bayer AG
- FIG 28 Swot Analysis: Qiagen N.V.
- FIG 29 SWOT Analysis: Siemens AG
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.